共查询到20条相似文献,搜索用时 31 毫秒
1.
The objective of the present investigation was to improve the dissolution rate of Rofecoxib (RXB), a poorly water-soluble
drug by solid dispersion technique using a water-soluble carrier, Poloxamer 188 (PXM). The melting method was used to prepare
solid dispersions. A 32 full factorial design approach was used for optimization wherein the temperature to which the melt-drug mixture cooled (X
1) and the drug-to-polymer ratio (X
2) were selected as independent variables and the time required for 90% drug dissolution (t90) was selected as the dependent variable. Multiple linear regression analysis revealed that for obtaining higher dissolution
of RXB from PXM solid dispersions, a low level ofX
1 and a high level ofX
2 were suitable. The differential scanning calorimetry and x-ray diffraction studies demonstrated that enhanced dissolution
of RXB from solid dispersion might be due to a decrease in the crystallinity of RXB and PXM and dissolution of RXB in molten
PXM during solid dispersion preparation. In conclusion, dissolution enhancement of RXB was obtained by preparing its solid
dispersions in PXM using melting technique. The use of a factorial design approach helped in identifying the critical factors
in the preparation and formulation of solid dispersion.
Published: April 13, 2007 相似文献
2.
The purpose of this study was to enhance the dissolution of total flavones of Hippophae rhamnoides L. (TFH) by solid dispersions consisting of the drug and a polymeric carrier, poloxamer 188 (PXM). The solvent evaporation
method was used to prepare solid dispersions. A 32 full-factorial design approach was used for optimization wherein the amount of solvent (X
1) and the drug-to-polymer ratio (X
2) were selected as independent variables and the percentage of TFH dissolved in 10 min (Q
10) was selected as the dependent variable. Multiple linear regression analysis revealed that a suitable level of X
1 and X
2 was required for obtaining higher dissolution of TFH from PXM solid dispersions. Solid dispersions were characterized by
differential scanning calorimetry, X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy,
and dissolution tests. Characterization studies revealed that solid dispersion of TFH–PXM showed enhancement of TFH dissolution
due to the conversion of TFH into a less crystalline and/or amorphous form. In conclusion, dissolution enhancement of TFH
was obtained by preparing its solid dispersions in PXM using solvent method. 相似文献
3.
The objective of this work was to study dissolution enhancement efficiency and solid dispersion formation ability of hydrophilic
swellable polymers such as sodium carboxymethyl cellulose (Na-CMC), sodium starch glycolate (SSG), pregelatinized starch (PGS),
and hydroxypropylmethyl cellulose (HPMC) with carbamazepine using 32 full factorial design for each of the polymers. Solid dispersions of carbamazepine were prepared using solvent evaporation
method with around 70% solvent recovery. The independent variables were the amount of polymer and organic solvent. The dependent
variables assessed were percentage drug dissolved at various time points and dispersion efficiency (ie, in terms of particle
size of solid dispersion). Solid dispersions were evaluated for percentage drug dissolved, wettability, differential scanning
calorimetry, scanning electron microscopy, and angle of repose. Multiple linear regression of results obtained led to equations,
which generated contour plots to relate the dependent variables. Similarity factor and mean dissolution time were used to
compare dissolution patterns obtained in distilled water and simulated gastric fluid United States Pharmacopeia (USP) XXVI
of pH 1.2. Maximum drug dissolution was obtained with polymer order Na-CMC>SSG>PGS>HPMC. Particle size of drug was reduced
≈ 10–15, 3–5, 5–7, and 10–25 times in Na-CMC, SSG, PGS, and HPMC solid dispersions, respectively; whereas wettability of solid
dispersions was found in the order of Na-CMC>HPMC>PGS>SSG. Angle of repose was found to be in the range of 29° to 35° for
all solid dispersions, which shows good flowability characteristics. HPMC showed increase in drug dissolution up to an optimized
level; however, furthers increase in its concentration decreased drug dissolution.
Published: April 6, 2007 相似文献
4.
The aim was to evaluate the influence of N-trimethyl chitosan chloride (TMC) as a carrier for solid dispersion on the dissolution of poorly water-soluble drugs. In this study, we used cyclosporin A(CyA) as a model drug and TMC as a carrier. The effect of various formulation and process variables including TMC-to-CyA mixing weight ratio, weigh molecular(Mw) of TMC and methods used to disperse CyA along with the TMC on the drug dissolution was investigated. The nature of CyA dispersed in the matrix was studied by powder X-ray diffractometry (PXRD), diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), and dissolution rate analyses. It was proved that all solid mixtures of CyA with TMCs showed a significantly rapid dissolution rate compared to pure drug and physical mixture. The greater the TMC content the higher the drug dissolution was, up to a maximum corresponding to a polymer: drug ratio of 3:1. The lower the Mw of TMC, the more important the polymer effect was. The dissolution of CyA was remarkably improved by the solid dispersion. The drug dissolution enhancement was attributed to the decreased drug crystallinity and size and polymer wetting effect. There was no significant difference in the efficiency of improving the drug dissolution between the solid dispersions prepared by solvent dispersing and by co-grinding. It was suggested that the TMC with a lower molecular weight is a useful carrier for solid dispersion. 相似文献
5.
The stability and dissolution properties of griseofulvin binary and ternary solid dispersions were evaluated. Solid dispersions
of griseofulvin and hydroxypropyl methylcellulose acetate succinate (HPMCAS) were prepared using the spray drying method.
A third polymer, poly[N-(2-hydroxypropyl)methacrylate] (PHPMA), was incorporated to investigate its effect on the interaction of griseofulvin with
HPMCAS. In this case, HPMCAS can form H bonds with griseofulvin directly; the addition of PHPMA to the solid dispersion may
enhance the stability of the amorphous griseofulvin due to greater interaction with griseofulvin. The X-ray powder diffraction
results showed that griseofulvin (binary and ternary solid dispersions) remained amorphous for more than 19 months stored
at 85% RH compared with the spray-dried griseofulvin which crystallized totally within 24 h at ambient conditions. The Fourier
transform infrared scan showed that griseofulvin carbonyl group formed hydrogen bonds with the hydroxyl group in the HPMCAS,
which could explain the extended stability of the drug. Further broadening in the peak could be seen when PHPMA was added
to the solid dispersion, which indicates stronger interaction. The glass transition temperatures increased in the ternary
solid dispersions regardless of HPMCAS grade. The dissolution rate of the drug in the solid dispersion (both binary and ternary)
has significantly increased when compared with the dissolution profile of the spray-dried griseofulvin. These results reveal
significant stability of the amorphous form due to the hydrogen bond formation with the polymer. The addition of the third
polymer improved the stability but had a minor impact on dissolution. 相似文献
6.
Improved Bioavailability of Poorly Water-Soluble Drug Curcumin in Cellulose Acetate Solid Dispersion
Curcumin (Cur), one of the most widely used natural active constituents with a great variety of beneficial biological and
pharmacological activities, is a practically water-insoluble substance with a short biologic half-life. The aim of this study
was to develop a sustained-release solid dispersion by employing water-insoluble carrier cellulose acetate for solubility
enhancement, release control, and oral bioavailability improvement of Cur. Solid dispersions were characterized by solubility,
in vitro drug release, Fourier transform infrared spectroscopy, X-ray diffractometry, and differential scanning calorimetry studies.
The in vivo performance was assessed by a pharmacokinetic study. Solid-state characterization techniques revealed the amorphous nature
of Cur in solid dispersions. Solubility/dissolution of Cur was enhanced in the formulations in comparison with pure drug.
Sustained-release profiles of Cur from the solid dispersions were ideally controlled in vitro up to 12 h. The optimized formulation provided an improved pharmacokinetic parameter (C
max = 187.03 ng/ml, t
max = 1.95 h) in rats as compared with pure drug (C
max = 87.06 ng/ml, t
max = 0.66 h). The information from this study suggests that the developed solid dispersions successfully enhanced the solubility
and sustained release of poorly water-soluble drug Cur, thus improving its oral bioavailability effectively. 相似文献
7.
Michael M. Puppolo Justin R. Hughey Traciann Dillon David Storey Susan Jansen-Varnum 《AAPS PharmSciTech》2017,18(8):2841-2853
The presented study describes the development of a membrane permeation non-sink dissolution method that can provide analysis of complete drug speciation and emulate the in vivo performance of poorly water-soluble Biopharmaceutical Classification System class II compounds. The designed membrane permeation methodology permits evaluation of free/dissolved/unbound drug from amorphous solid dispersion formulations with the use of a two-cell apparatus, biorelevant dissolution media, and a biomimetic polymer membrane. It offers insight into oral drug dissolution, permeation, and absorption. Amorphous solid dispersions of felodipine were prepared by hot melt extrusion and spray drying techniques and evaluated for in vitro performance. Prior to ranking performance of extruded and spray-dried felodipine solid dispersions, optimization of the dissolution methodology was performed for parameters such as agitation rate, membrane type, and membrane pore size. The particle size and zeta potential were analyzed during dissolution experiments to understand drug/polymer speciation and supersaturation sustainment of felodipine solid dispersions. Bland-Altman analysis was performed to measure the agreement or equivalence between dissolution profiles acquired using polymer membranes and porcine intestines and to establish the biomimetic nature of the treated polymer membranes. The utility of the membrane permeation dissolution methodology is seen during the evaluation of felodipine solid dispersions produced by spray drying and hot melt extrusion. The membrane permeation dissolution methodology can suggest formulation performance and be employed as a screening tool for selection of candidates to move forward to pharmacokinetic studies. Furthermore, the presented model is a cost-effective technique. 相似文献
8.
This article investigates enhancement of the dissolution profile of valdecoxib using solid dispersion with PVP. The article
also describes the preparation of fast-dissolving tablets of valdecoxib by using a high amount of superdisintegrants. A phase
solubility method was used to evaluate the effect of various water-soluble polymers on aqueous solubility of valdecoxib. Polyvinyl
pyrrolidone (PVP K-30) was selected and solid dispersions were prepared by the method of kneading. Dissolution studies, using
the USP paddle method were performed for solid dispersions of valdecoxib. Infrared (IR) spectroscopy, differential scanning
calorimetry (DSC), and x-ray diffractometry (XRD) were performed to identify the physicochemical interaction between drug
and carrier, hence its effect on dissolution. Tablets were formulated containing solid dispersion products and compared with
commercial products. IR spectroscopy, XRD, and DSC showed no change in the crystal structure of valdecoxib. Dissolution of
valdecoxib improved significantly in solid dispersion products (<85% in 5 minutes). Tablets containing solid dispersion exhibited
better dissolution profile than commercial tablets. Thus, the solid dispersion technique can be successfully used for improvement
of dissolution of valdecoxib.
Published: August 18, 2006 相似文献
9.
Developing amorphous solid dispersions of water-insoluble molecules using polymeric materials is a well-defined approach to improve the dissolution rate and bioavailability. While the selected polymer plays a vital role in stabilizing the amorphous solid dispersion physically, it is equally important to improve the dissolution profile by inhibiting crystallization from the supersaturated solution generated by dissolution of the amorphous material. Furthermore, understanding the mechanism of dissolution rate enhancement is of vital importance. In this work, wetting kinetics was taken up as an alternative approach for understanding the enhanced dissolution rate for amorphous solid dispersion of a poorly soluble drug. While cilostazol (CIL) was selected as the model drug, povidone (PVP), copovidone, and hypromellose (HPMC) were the polymers of choice. The concentrations against time profiles were evaluated for the supersaturated solutions of CIL in the presence and absence of the selected polymers. The degree of supersaturation increased significantly with increase in polymer content within the solid dispersion. While povidone was found to maintain the highest level of supersaturation for the greatest length of time both in dissolution and solution crystallization experiments, copovidone and hypromellose were found to be the less effective as crystallization inhibitor. The ability of polymers to generate and maintain supersaturated drug solutions was assessed by dissolution studies. The wetting kinetics was compared against the solid dispersion composition to establish a correlation with enhanced dissolution rate.KEY WORDS: Cilostazol, Crystallization inhibition, Solid dispersions, Supersaturated solutions, Wetting kinetics 相似文献
10.
The purpose of the present investigation was to increase the solubility and dissolution rate of rofecoxib by the preparation
of its solid dispersion with polyvinyl pyrrolidone K30 (PVP K30) using solvent evaporation method. Drug-polymer interactions
were investigated using differential scanning calorimetry (DSC), x-ray diffraction (XRD), and Fourier transform infrared spectroscopy
(FTIR). For the preparation of rofecoxib mouth dissolve tablets, its 1∶9 solid dispersion with PVP K30 was used with various
disintegrants and sublimable materials. In an attempt to construct a statistical model for the prediction of disintegration
time and percentage friability, a 32 randomized full and reduced factorial design was used to optimize the influence of the amounts of superdisintegrant and subliming
agent. The obtained results showed that dispersion of the drug in the polymer considerably enhanced the dissolution rate.
The drug-to-carrier ratio was the controlling factor for dissolution improvement. FTIR spectra revealed no chemical incompatibility
between the drug and PVP K30. As indicated from XRD and DSC data, rofecoxib was in the amorphous form, which explains the
better dissolution rate of the drug from its solid dispersions. Concerning the optimization study, the multiple regression
analysis revealed that an optimum concentration of camphor and a higher percentage of crospovidone are required for obtaining
rapidly disintegrating tablets. In conclusion, this investigation demonstrated the potential of experimental design in understanding
the effect of the formulation variables on the quality of mouth dissolve tablets containing solid dispersion of a hydrophobic
drug. 相似文献
11.
The purpose of this research was to prepare and evaluate sustained release mucoadhesive tablets of Itraconazole. It is practically
insoluble in aqueous fluids hence its solid dispersion with Eudragit E100 was prepared by spray drying. This was formulated
in matrix of hydrophilic mucoadhesive polymers Carbopol 934P (CP) and Methocel K4M (HPMC). The formulation was optimized using
a 32 factorial design. Amounts of CP and HPMC were taken as formulation variables for optimizing response variables i.e. mucoadhesion
and dissolution parameters. The optimized mucoadhesive formulation was orally administered to albino rabbits, and blood samples
collected were used to determine pharmacokinetic parameters. The solid dispersion markedly enhanced the dissolution rate of
itraconazole. The bioadhesive strength of formulation was found to vary linearly with increasing amount of both polymers.
Formulations exhibited drug release fitting Peppas model with value of n ranging from 0.61 to 1.18. Optimum combination of polymers was arrived at which provided adequate bioadhesive strength and
fairly regulated release profile. The experimental and predicted results for optimum formulations were found to be in close
agreement. The formulation showed C
max 1898 ± 75.23 ng/ml, t
max of the formulation was 2 h and AUC was observed to be 28604.9 ng h/ml 相似文献
12.
Gliclazide (GLI), a poorly water-soluble antidiabetic, was transformed into a glassy state by melt quench technique in order to improve its physicochemical properties. Chemical stability of GLI during formation of glass was assessed by monitoring thin-layer chromatography, and an existence of amorphous form was confirmed by differential scanning calorimetry and X-ray powder diffractometry. The glass transition occurred at 67.5°C. The amorphous material thus generated was examined for its in vitro dissolution performance in phosphate buffer (pH 6.8). Surprisingly, amorphous GLI did not perform well and was unable to improve the dissolution characteristics compared to pure drug over entire period of dissolution studies. These unexpected results might be due to the formation of a cohesive supercooled liquid state and structural relaxation of amorphous form toward the supercooled liquid region which indicated functional inability of amorphous GLI from stability point of view. Hence, stabilization of amorphous GLI was attempted by elevation of Tg via formation of solid dispersion systems involving comprehensive antiplasticizing as well as surface adsorption mechanisms. The binary and ternary amorphous dispersions prepared with polyvinylpyrrolidone K30 (as antiplasticizer for elevation of Tg) and Aerosil 200® and/or Sylysia® 350 (as adsorbent) in the ratio of 1:1:1 (w/w) using kneading and spray-drying techniques demonstrated significant enhancement in rate and extent of dissolution of drug initially. During accelerated stability studies, ternary systems showed no significant reduction in drug dissolution performance over a period of 3 months indicating excellent stabilization of amorphous GLI.Key words: amorphous, gliclazide, solid dispersion, stability studies, Tg 相似文献
13.
The aim of the current study was to design oral fast-release polymeric tablets of prednisone and to optimize the drug dissolution profile by modifying the carrier concentration. Solid dispersions were prepared by the solvent evaporation method at different drug:polymer ratios (wt/wt). The physical state and drug:carrier interactions were analyzed by X-ray diffraction, infrared spectroscopy, and scanning electron microscopy. The dissolution rate of prednisone from solid dispersions was markedly enhanced by increasing the polymer concentration. The tablets were prepared from solid dispersion systems using polyethylene glycol (PEG) 6000 as a carrier at low and high concentration. The results showed that PEG 6000-based tablets exhibited a significantly higher prednisone dissolution (80% within 30 minutes) than did conventional tablets prepared without PEG 6000 (<25% within 30 minutes). In addition, the good disintegration and very good dissolution performance of the developed tablets without the addition of superdisintegrant highlighted the suitability of these formulated dosage forms. The stability studies performed in normal and accelerated conditions during 12 months showed that prednisone exhibited high stability in PEG 6000 solid dispersion powders and tablets. The X-ray diffraction showed that the degree of crystallinity of prednisone in solid dispersions decreased when the ratio of the polymer increased, suggesting that the drug is present inside the samples in different physical states. The Fourier transform infrared spectroscopic studies showed the stability of prednisone and the absence of well-defined drug:polymer interactions. Scanning electron microscopy images showed a novel morphology of the dispersed systems in comparison with the pure components. 相似文献
14.
Shilpi Sinha Mushir Ali Sanjula Baboota Alka Ahuja Anil Kumar Javed Ali 《AAPS PharmSciTech》2010,11(2):518-527
Ritonavir is an antiretroviral drug characterized by low solubility and high permeability which corresponds to BCS class II
drug. The purpose of the study was to develop solid dispersion by different methods and investigate them for in vitro and in vivo performance for enhancing dissolution and bioavailability, respectively. Since the drug possesses food-related absorption,
the effect of biorelevant media (FaSSIF and FeSSIF state) on dissolution behavior was also studied. The solid dispersion was
prepared using Gelucire as carrier in 1:4 ratio by different methods and were characterized for differential scanning calorimetry
(DSC), X-ray diffractometry, scanning electron microscopy, and FT-IR. Oral bioavailability of 10 mg of ritonavir in solid
dispersion prepared by solvent evaporation (SE1) and melt method (MM1) was compared with pure drug after oral administration
of solid dispersion and pure drug to Albino Wistar rats of either sex. The results suggested formation of eutectic solid dispersion.
In vitro dissolution studies was performed in 0.1 N HCl and biorelevant media showed enhanced dissolution rate as compared to pure
drug in both FeSSIF media and 0.1 N HCl. The apparent rate of absorption of ritonavir from SE1 (C
max 20221.37 ng/ml, t
max 0.5 h) was higher than that of MM1 (C
max 2,462.2, t
max 1 h) and pure drug (C
max 1,354.8 ng/ml, t
max 0.5 h). On the basis of the result obtained, it was concluded that solid dispersion is a good approach to enhance solubility
and bioavailability of poorly water-soluble ritonavir. 相似文献
15.
Peng Hou Jian Ni Sali Cao Haimin Lei Zhengjun Cai Tao Zhang Fang Yu Qingzhong Tan 《AAPS PharmSciTech》2013,14(2):629-638
Ensuring sufficient drug solubility is a crucial problem in pharmaceutical-related research. For water-insoluble drugs, various formulation approaches are employed to enhance the solubility and bioavailability of lead compounds. The goal of this study was to enhance the dissolution and absorption of a new antitumor lead compound, T-OA. Early-stage preparation discovery concept was employed in this study. Based on this concept, a solid dispersion system was chosen as the method of improving drug solubility and bioavailability. Solid dispersions of T-OA in polyvinylpyrrolidone (PVP) K30 were prepared by the solvent evaporation method. Dissolution testing determined that the ideal drug-to-PVP ratio was 1:5. X-ray diffraction, Fourier transform infrared spectroscopy, and differential scanning calorimetry were employed to confirm the formation of solid dispersions. Scanning electron microscopy demonstrated that T-OA was converted into an amorphous form. Both in vitro dissolution testing and the in vivo studies demonstrated that the solubility and bioavailability of T-OA were significantly improved when formulated in a solid dispersion with PVP. The dissolution rate of the T-OA/PVP solid dispersion was greatly enhanced relative to the pure drug, and the relative bioavailability of T-OA solid dispersions was found to be 392.0%, which is 4-fold higher than the pure drug. 相似文献
16.
The purpose of this study was to enhance the dissolution of oleanolic acid by solid dispersions consisting of the drug, a polymeric carrier, and a surfactant. Binary solid dispersions consisting of oleanolic acid and polyvinylpyrrolidone were prepared for comparison. Polysorbate 80, a nonionic surfactant, was incorporated into binary solid dispersions as the third component to prepare ternary solid dispersions. Solid dispersions were characterized by differential scanning calorimetry, Fourier transform infrared spectroscopy, and dissolution tests. The crystallinization of OA was prohibited in solid dispersions. Both the binary and ternary solid dispersions enhanced the dissolution of OA. Moreover, the dissolution of ternary solid dispersion was faster compared with that of binary solid dispersion. Polysorbate 80 played an important positive role in dissolution of the solid dispersion. 相似文献
17.
Roberta Censi Maria Rosa Gigliobianco Alessandra Dubbini Ladjan Malaj Piera Di Martino 《AAPS PharmSciTech》2016,17(5):1204-1212
To improve the poor water solubility and dissolution rate of the oral hypoglycemic drug glibenclamide, it was molecularly dispersed in Neusilin® UFL2, an amorphous synthetic form of magnesium aluminometasilicate, at different proportions; the physicochemical and biopharmaceutical properties, as well as the stability of the four different batches recovered were characterised, and it was determined that complete dispersion of glibenclamide in the amorphous polymer was obtained at the drug to Neusilin ratio of 1 to 2.5. Completely amorphous dispersion was proven by Thermal Analysis and X-Ray Powder Diffractometry. Very small particles were obtained, ranging from approximately 200 to 400 nm. The amorphous batches were physically and chemically stable for the entire duration of experiments. The physicochemical properties of the four batches were compared to those of the starting materials and physical mixtures of Neusilin® UFL2 and glibenclamide, the latter showing the typical behaviour of simple mixes, i.e., the additivity of properties of single components. The dissolution studies of the four solid dispersions revealed a very high dissolution rate of the completely amorphous batches (Batches 3 and 4), behaviour that was ascribed to their high Intrinsic dissolution rate due to the amorphous characteristics of the solid dispersions, to their very small particle size, and to the presence of polysorbate 80 that improved solid wettability. The technique under investigation thus proved effective for recovering stable amorphous dispersions of very small particle sizes. 相似文献
18.
The aim of the present study was to improve the solubility of poorly water soluble drug lovastatin (LS) by solid dispersion
(SD) techniques using modified locust bean gum (MLBG) as a carrier. The locust bean gum (LBG) was modified by heating and
there observed irreversible decrease in viscosity, whereas swelling property remains unaffected. The advantage of modification
of LBG was illustrated by difference in dissolution profiles of their SD. Effect of polymer concentration and methods of preparation
on solubility enhancement were studied using solubility and dissolution studies, respectively. The result of solubility study
showed increase in solubility of LS with increase in concentration of MLBG. It was found that the dissolution rate of LS from
its SD was dependent on the method of preparation of solid dispersions. Dissolution study revealed that the modified solvent
evaporation is most convenient and effective method for solubility enhancement of poorly water soluble drug LS, among various
methods of preparation of SD. The prepared SDs were characterized by differential scanning calorimetry, scanning electron
microscopy, and X-ray diffraction study. In vivo study was performed by measuring 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG Co-A) reductase inhibition activity. Significant
reduction in HMG Co-A reductase activity was observed in case of solid dispersions of LS than plain LS. In conclusion, MLBG
could be used as a potential carrier in enhancing the dissolution rate and bioavailability of LS. 相似文献
19.
Chris Brough Dave A. Miller Daniel Ellenberger Dieter Lubda Robert O. WilliamsIII 《AAPS PharmSciTech》2016,17(1):180-190
The KinetiSol® Dispersing (KSD) technology has enabled the investigation into the use of polyvinyl alcohol (PVAL) as a concentration enhancing polymer for amorphous solid dispersions. Our previous study revealed that the 88% hydrolyzed grade of PVAL was optimal for itraconazole (ITZ) amorphous compositions with regard to solid-state properties, non-sink dissolution performance, and bioavailability enhancement. The current study investigates the influence of molecular weight for the 88% hydrolyzed grades of PVAL on the properties of KSD processed ITZ:PVAL amorphous dispersions. Specifically, molecular weights in the processable range of 4 to 18 mPa · s were evaluated and the 4-88 grade provided the highest AUC dissolution profile. Amorphous dispersions at 10, 20, 30, 40, and 50% ITZ drug loads in PVAL 4-88 were also compared by dissolution performance. Analytical tools of diffusion-ordered spectroscopy and Fourier transform infrared spectroscopy were employed to understand the interaction between drug and polymer. Finally, results from a 30-month stability test of a 30% drug loaded ITZ:PVAL 4-88 composition shows that stable amorphous dispersions can be achieved. Thus, this newly enabled polymer carrier can be considered a viable option for pharmaceutical formulation development for solubility enhancement.KEY WORDS: amorphous solid dispersion, itraconazole, polyvinyl alcohol, PVAL, solubility enhancement 相似文献
20.
The purpose of this research was to prepare a gastroretentive drug delivery system of ranitidine hydrochloride. Guar gum,
xanthan gum, and hydroxypropyl methylcellulose were evaluated for gel-forming properties. Sodium bicarbonate was incorporated
as a gas-generating agent. The effects of citric acid and stearic acid on drug release profile and floating properties were
investigated. The addition of stearic acid reduces the drug dissolution due to its hydrophobic nature. A 32 full factorial design was applied to systemically optimize the drug release profile. The amounts of citric acid anhydrous
(X1) and stearic acid (X2) were selected as independent variables. The times required for 50% (t50) and 80% drug dissolution (t80), and the similarity factor f2 were selected as dependent variables. The results of the full factorial design indicated that a low amount of citric acid
and a high amount of stearic acid favors sustained release of ranitidine hydrochloride from a gastroretentive formulation.
A theoretical dissolution profile was generated using pharmacokinetic parameters of ranitidine hydrochloride. The similarity
factor f2 was applied between the factorial design batches and the theoretical dissolution profile. No significant difference was observed
between the desired release profile and batches F2, F3, F6, and F9. Batch F9 showed the highest f2 (f2=75) among all the batches,
and this similarity is also reflected in t50 (∼214 minutes) and t80 (∼537 minutes) values. These studies indicate that the proper balance between a release rate enhancer and a release rate
retardant can produce a drug dissolution profile similar to a theoretical dissolution profile. 相似文献